Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38587254
2.
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
Circulation
; 147(13): 1026-1038, 2023 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36802876
3.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37335828
4.
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
Am Heart J
; 272: 11-22, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38458371
5.
CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.
Arterioscler Thromb Vasc Biol
; 43(6): 855-869, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36994730
6.
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.
Cochrane Database Syst Rev
; 1: CD014678, 2024 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38264795
7.
Early technology review: towards an expedited pathway.
Int J Technol Assess Health Care
; 40(1): e13, 2024 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38282208
8.
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
Eur Heart J
; 44(20): 1780-1794, 2023 05 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36988155
9.
Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study.
Circulation
; 145(2): 97-106, 2022 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34743530
10.
Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study.
Am Heart J
; 259: 30-41, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36642226
11.
Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.
Am Heart J
; 258: 119-128, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36592878
12.
Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
Am Heart J
; 262: 75-82, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37088164
13.
Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study.
Am Heart J
; 266: 128-137, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37703948
14.
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
J Thromb Thrombolysis
; 55(2): 211-221, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36566304
15.
Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.
J Thromb Thrombolysis
; 56(4): 499-510, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37563502
16.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34710343
17.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33148016
18.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33587654
19.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
Circulation
; 143(6): 583-596, 2021 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33555916
20.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation
; 143(5): 479-500, 2021 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33523728